Surgical nerve decompression, used to treat conditions such as carpal tunnel syndrome and sciatica, could play a role in relieving the pain of diabetic neuropathy patients, researchers at UT Southwestern Medical Center found.
Mar 20, 2024
0
0
New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizumab to chemotherapy before and after surgery for breast cancer leads to better outcomes for patients regardless of their ...
Mar 19, 2024
0
1
Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.
Mar 8, 2024
0
10
For scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.
Mar 6, 2024
0
0
For patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARĪ“) agonist seladelpar have a biochemical response and alkaline phosphatase normalization, according ...
Feb 27, 2024
0
0
A single dose of subcutaneous zilebesiran is associated with a reduction in systolic blood pressure (SBP), according to a study published online Feb. 16 in the Journal of the American Medical Association.
Feb 20, 2024
0
1
Melatonin treatment does not affect the insulin resistance or the glucose tolerance of night shift workers, according to a new study from the University of Surrey and the University Medical Centre Hamburg. Melatonin treatment ...
Feb 19, 2024
0
0
The U.S. Food and Drug Administration has approved Takeda's Eohilia (budesonide oral suspension) as the first and only oral treatment for eosinophilic esophagitis (EoE).
Feb 19, 2024
0
1
Researchers at Ghent University Hospital, Ghent University, and VIB-UGent Center for Inflammation Research, show that antibody therapy can be effective against erosive hand osteoarthritis. Using the antibody denosumab leads ...
Feb 15, 2024
0
48
For patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weighted lesions, according to a study published in the Feb. ...
Feb 15, 2024
0
0
